Military Medical Research,
Год журнала:
2024,
Номер
11(1)
Опубликована: Янв. 23, 2024
Abstract
Antimicrobial
resistance
is
a
global
public
health
threat,
and
the
World
Health
Organization
(WHO)
has
announced
priority
list
of
most
threatening
pathogens
against
which
novel
antibiotics
need
to
be
developed.
The
discovery
introduction
are
time-consuming
expensive.
According
WHO’s
report
antibacterial
agents
in
clinical
development,
only
18
have
been
approved
since
2014.
Therefore,
critically
needed.
Artificial
intelligence
(AI)
rapidly
applied
drug
development
its
recent
technical
breakthrough
dramatically
improved
efficiency
antibiotics.
Here,
we
first
summarized
recently
marketed
antibiotics,
antibiotic
candidates
development.
In
addition,
systematically
reviewed
involvement
AI
utilization,
including
small
molecules,
antimicrobial
peptides,
phage
therapy,
essential
oils,
as
well
mechanism
prediction,
stewardship.
Abstract
Antimicrobial
peptides
(AMPs)
are
essential
elements
of
thehost
defense
system.
Characterized
by
heterogenous
structures
and
broad‐spectrumaction,
they
promising
candidates
for
combating
multidrug
resistance.
Thecombined
use
AMPs
with
other
antimicrobial
agents
provides
a
new
arsenal
ofdrugs
synergistic
action,
thereby
overcoming
the
drawback
monotherapiesduring
infections.
kill
microbes
via
pore
formation,
thus
inhibitingintracellular
functions.
This
mechanism
action
is
an
advantage
overantibiotics
as
it
hinders
development
drug
The
synergisticeffect
will
allow
repurposing
conventional
antimicrobials
andenhance
their
clinical
outcomes,
reduce
toxicity,
and,
most
significantly,prevent
In
this
review,
various
synergies
ofAMPs
miscellaneous
discussed.
effect
ofstructural
diversity
chemical
modification
on
AMP
properties
firstaddressed
then
different
combinations
that
can
lead
to
action,whether
combination
between
antimicrobials,
or
andmiscellaneous
compounds,
attended.
review
serve
guidance
whenredesigning
in
antimicrobialagents
enhanced
outcomes.
Applied Microbiology,
Год журнала:
2023,
Номер
3(3), С. 629 - 665
Опубликована: Июнь 26, 2023
Biofilm
formation
can
lead
to
problems
in
healthcare,
water
distribution
systems,
food
processing
and
packaging,
industrial
manufacturing,
marine
industries,
sanitation.
These
microbial
communities
proliferate
on
biotic
or
abiotic
surfaces,
are
responsible
for
human
disease
decreasing
production
efficiency
service
equipment
life
many
fields.
The
of
biofilm
starts
with
the
attachment
bacteria
surface,
followed
by
bacterial
proliferation
maturation
community.
After
forming
a
biofilm,
not
resistant
antimicrobial
agents
their
planktonic
forms
turn
resistant.
antibiotic
resistance
association
biofilms
generating
infectious
diseases
humans,
highlight
need
designing
novel
successful
antibacterial,
anti-biofilm,
anti-infection
materials.
This
paper
aims
review
mechanism
formation,
impact
different
interaction
nanoparticles
bacteria,
strategies
design
anti-biofilm
Examples
bio-implants,
coatings,
medical
devices,
wound
dressings,
sutures
reviewed.
Antibiotics,
Год журнала:
2023,
Номер
12(3), С. 523 - 523
Опубликована: Март 6, 2023
Antimicrobial
resistance
(AMR)
is
emerging
as
a
potential
threat
to
many
lives
worldwide.
It
very
important
understand
and
apply
effective
strategies
counter
the
impact
of
AMR
its
mutation
from
medical
treatment
point
view.
The
intersection
artificial
intelligence
(AI),
especially
deep
learning/machine
learning,
has
led
new
direction
in
antimicrobial
identification.
Furthermore,
presently,
availability
huge
amounts
data
multiple
sources
made
it
more
use
these
techniques
identify
interesting
insights
into
genes
such
genes,
mutations,
drug
identification,
conditions
favorable
spread,
so
on.
Therefore,
this
paper
presents
review
state-of-the-art
challenges
opportunities.
These
include
input
features
posing
use,
deep-learning/machine-learning
models
for
robustness
high
accuracy,
challenges,
prospects
practical
purposes.
concludes
with
encouragement
AI
sector
intention
diagnosis
treatment,
since
presently
most
studies
are
at
early
stages
minimal
application
practice
disease.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Ноя. 8, 2023
Bioactive
peptides
are
key
molecules
in
health
and
medicine.
Deep
learning
holds
a
big
promise
for
the
discovery
design
of
bioactive
peptides.
Yet,
suitable
experimental
approaches
required
to
validate
candidates
high
throughput
at
low
cost.
Here,
we
established
cell-free
protein
synthesis
(CFPS)
pipeline
rapid
inexpensive
production
antimicrobial
(AMPs)
directly
from
DNA
templates.
To
our
platform,
used
deep
thousands
AMPs
de
novo.
Using
computational
methods,
prioritized
500
that
produced
screened
with
CFPS
pipeline.
We
identified
30
functional
AMPs,
which
characterized
further
through
molecular
dynamics
simulations,
activity
toxicity.
Notably,
six
novo-AMPs
feature
broad-spectrum
against
multidrug-resistant
pathogens
do
not
develop
bacterial
resistance.
Our
work
demonstrates
potential
low-cost
testing
within
less
than
24
h.
ACS Infectious Diseases,
Год журнала:
2023,
Номер
9(7), С. 1283 - 1302
Опубликована: Июнь 22, 2023
The
emergence
of
antibiotic-resistant
bacterial
strains
is
a
source
public
health
concern
across
the
globe.
As
discovery
new
conventional
antibiotics
has
stalled
significantly
over
past
decade,
there
an
urgency
to
develop
novel
approaches
address
drug
resistance
in
infectious
diseases.
use
CRISPR-Cas-based
system
for
precise
elimination
targeted
populations
holds
promise
as
innovative
approach
antimicrobial
agent
design.
CRISPR-Cas
targeting
celebrated
its
high
versatility
and
specificity,
offering
excellent
opportunity
fight
antibiotic
pathogens
by
selectively
inactivating
genes
involved
resistance,
biofilm
formation,
pathogenicity,
virulence,
or
viability.
strategy
can
enact
effects
two
approaches:
inactivation
chromosomal
curing
plasmids
encoding
resistance.
In
this
Review,
we
provide
overview
main
systems
utilized
creation
these
antimicrobials,
well
highlighting
promising
studies
field.
We
also
offer
detailed
discussion
about
most
commonly
used
mechanisms
delivery:
bacteriophages,
nanoparticles,
conjugative
plasmids.
Lastly,
possible
interference
that
should
be
considered
during
intelligent
design
approaches.
Cell,
Год журнала:
2023,
Номер
186(19), С. 4059 - 4073.e27
Опубликована: Авг. 22, 2023
Antimicrobial
resistance
is
a
leading
mortality
factor
worldwide.
Here,
we
report
the
discovery
of
clovibactin,
an
antibiotic
isolated
from
uncultured
soil
bacteria.
Clovibactin
efficiently
kills
drug-resistant
Gram-positive
bacterial
pathogens
without
detectable
resistance.
Using
biochemical
assays,
solid-state
nuclear
magnetic
resonance,
and
atomic
force
microscopy,
dissect
its
mode
action.
blocks
cell
wall
synthesis
by
targeting
pyrophosphate
multiple
essential
peptidoglycan
precursors
(C55PP,
lipid
II,
IIIWTA).
uses
unusual
hydrophobic
interface
to
tightly
wrap
around
but
bypasses
variable
structural
elements
precursors,
accounting
for
lack
Selective
efficient
target
binding
achieved
sequestration
into
supramolecular
fibrils
that
only
form
on
membranes
contain
lipid-anchored
groups.
This
potent
holds
promise
enabling
design
improved
therapeutics
kill
development.
Chemical Society Reviews,
Год журнала:
2023,
Номер
52(11), С. 3663 - 3740
Опубликована: Янв. 1, 2023
Carbohydrates
are
essential
mediators
of
many
processes
in
health
and
disease.
The
development
glycomimetics
as
inhibitors
modulators
their
lectin
receptors
has
been
a
success
story
with
numerous
molecules
reaching
clinical
stages.
npj Antimicrobials and Resistance,
Год журнала:
2023,
Номер
1(1)
Опубликована: Дек. 20, 2023
Emerging
resistance
to
all
available
antibiotics
highlights
the
need
develop
new
with
novel
mechanisms
of
action.
Most
currently
used
target
Gram-positive
bacteria
while
Gram-negative
easily
bypass
action
most
drug
molecules
because
their
unique
outer
membrane.
This
additional
layer
acts
as
a
potent
barrier
restricting
entry
compounds
into
cell.
In
this
scenario,
several
approaches
have
been
elucidated
increase
accumulation
bacteria.
review
includes
brief
description
physicochemical
properties
that
can
aid
enter
and
accumulate
in
covers
different
strategies
or
membrane-mediated
bacterial
pathogens.
Pharmacology & Pharmacy,
Год журнала:
2023,
Номер
14(08), С. 271 - 328
Опубликована: Янв. 1, 2023
Background:
Antimicrobial
resistance
(AMR)
is
a
global
health
challenge
that
has
escalated
due
to
the
inappropriate
use
of
antimicrobials
in
humans,
animals,
and
environment.
Developing
implementing
strategies
reduce
combat
AMR
critical.
Purpose:
This
study
aimed
highlight
some
can
be
implemented
address
using
One
Health
approach.
Methods:
employed
narrative
review
design
included
studies
published
from
January
2002
July
2023.
The
searched
for
literature
on
antimicrobial
stewardship
(AMS)
PubMed
Google
Scholar
2020
PRISMA
guidelines.
Results:
reveals
remains
significant
public
problem.
Its
severity
been
markedly
exacerbated
by
broader
ecological
Several
have
developed
AMR,
including
Global
Action
Plan
(GAP),
National
Plans
(NAPs),
AMS
programs,
implementation
AWaRe
classification
antimicrobials.
These
also
involve
strengthening
surveillance
consumption
resistance,
encouraging
development
new
antimicrobials,
enhancing
regulations
around
prescribing,
dispensing,
usage.
Additional
measures
include
promoting
partnerships,
combating
substandard
falsified
advocating
vaccinations,
sanitation,
hygiene
biosecurity,
as
well
exploring
alternatives
However,
these
faces
various
challenges.
challenges
low
awareness
knowledge
shortage
human
resources
capacity
building
AMS,
adequate
funding
initiatives,
limited
laboratory
capacities
surveillance,
behavioural
change
issues,
ineffective
leadership
multidisciplinary
teams.
Conclusion:
In
conclusion,
this
established
prevalent
among
Successfully
addressing
calls
collaborative,
multifaceted
Despite
this,
gaps
remain
effectively
currently
recommended
AMR.
As
result,
it
essential
reinforce
are
deployed
counter
across
human,
animal,
environmental
sectors.